SIAT1 - PMC

Yipu Lin, Stephen A. Wharton, Lynne Whittaker, Mian Dai, Burcu Ermetal, Janice Lo, Andrea Pontoriero, Elsa Baumeister, Rodney S. Daniels, John W. McCauley

Influenza Other Respir Viruses. 2017 May; 11(3): 263–274. Published online 2017 Feb 28. doi: 10.1111/irv.12447

PMCID:: PMC5410720

Abstract Article PDF–541K

Select item 93257284.

Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies

Lauren Byrd-Leotis, Nan Jia, Yasuyuki Matsumoto, Dongli Lu, Yoshihiro Kawaoka, David A. Steinhauer, Richard D. Cummings

Sci Rep. 2022; 12: 12757. Published online 2022 Jul 26. doi: 10.1038/s41598-022-16605-5

PMCID:: PMC9325728

Abstract Article PDF–3.8M

Select item 24469045.

MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells

Ding Yuan Oh, Ian G. Barr, Jenny A. Mosse, Karen L. Laurie

J Clin Microbiol. 2008 Jul; 46(7): 2189–2194. Published online 2008 May 14. doi: 10.1128/JCM.00398-08

PMCID:: PMC2446904

Abstract Article PDF–284K

Select item 87041036.

Comparative Susceptibility of Madin–Darby Canine Kidney (MDCK) Derived Cell Lines for Isolation of Swine Origin Influenza A Viruses from Different Clinical Specimens

Matthew Suderman, Mariko Moniwa, Tamiru N. Alkie, Davor Ojkic, Andre Broes, Neil Pople, Yohannes Berhane

Viruses. 2021 Dec; 13(12): 2346. Published online 2021 Nov 23. doi: 10.3390/v13122346

PMCID:: PMC8704103

Abstract Article PDF–415K

Select item 38378567.

Cell Culture-Selected Substitutions in Influenza A(H3N2) Neuraminidase Affect Drug Susceptibility Assessment

Daisuke Tamura, Ha T. Nguyen, Katrina Sleeman, Marnie Levine, Vasiliy P. Mishin, Hua Yang, Zhu Guo, Margaret Okomo-Adhiambo, Xiyan Xu, James Stevens, Larisa V. Gubareva

Antimicrob Agents Chemother. 2013 Dec; 57(12): 6141–6146. doi: 10.1128/AAC.01364-13

PMCID:: PMC3837856

Abstract Article PDF–146K

Select item 50498788.

Sequence amplification via cell passaging creates spurious signals of positive adaptation in influenza virus H3N2 hemagglutinin

Claire D. McWhite, Austin G. Meyer, Claus O. Wilke

Virus Evol. 2016 Jul; 2(2): vew026. Published online 2016 Oct 3. doi: 10.1093/ve/vew026

PMCID:: PMC5049878

Abstract Article PDF–1.3M

Select item 26436699.

In Vivo and In Vitro Alterations in Influenza A/H3N2 Virus M2 and Hemagglutinin Genes: Effect of Passage in MDCK-SIAT1 Cells and Conventional MDCK Cells

Danjuan Li, Reiko Saito, Yasushi Suzuki, Isamu Sato, Hassan Zaraket, Clyde Dapat, Isolde Ma Caperig-Dapat, Hiroshi Suzuki

J Clin Microbiol. 2009 Feb; 47(2): 466–468. Published online 2008 Dec 17. doi: 10.1128/JCM.00892-08

PMCID:: PMC2643669

Abstract Article PDF–41K

Select item 756582810.

Cell-Based Influenza A/H1N1pdm09 Vaccine Viruses Containing Chimeric Hemagglutinin with Improved Membrane Fusion Ability

Madoka Kawahara, Toshiya Wada, Fumitaka Momose, Eri Nobusawa, Yuko Morikawa

Vaccines (Basel) 2020 Sep; 8(3): 458. Published online 2020 Aug 19. doi: 10.3390/vaccines8030458

PMCID:: PMC7565828

Abstract Article PDF–4.2M

Select item 742974311.

Alveolar macrophage‐derived extracellular vesicles inhibit endosomal fusion of influenza virus

Daniel J Schneider, Katherine A Smith, Catrina E Latuszek, Carol A Wilke, Danny M Lyons, Loka R Penke, Jennifer M Speth, Matangi Marthi, Joel A Swanson, Bethany B Moore, Adam S Lauring, Marc Peters‐Golden

EMBO J. 2020 Aug 17; 39(16): e105057. Published online 2020 Jul 9. doi: 10.15252/embj.2020105057

PMCID:: PMC7429743

Abstract Article PDF–894K

Select item 741444912.

Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding

Jonathan C. Brown, Wendy S. Barclay, Monica Galiano, Ruth Harvey

J Gen Virol. 2020 May; 101(5): 456–466. Published online 2019 Nov 8. doi: 10.1099/jgv.0.001348

PMCID:: PMC7414449

Abstract Article PDF–4.7M

Select item 397379713.

The expression of essential components for human influenza virus internalisation in Vero and MDCK cells

Maharani Ugiyadi, Marselina I. Tan, Ernawati A. Giri-Rachman, Fawzi R. Zuhairi, Sony H. Sumarsono

Cytotechnology. 2014 May; 66(3): 515–523. Published online 2013 Aug 4. doi: 10.1007/s10616-013-9602-2

PMCID:: PMC3973797

Abstract Article PDF–1.5M

Select item 16523614.

Overexpression of the α-2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors

Mikhail Matrosovich, Tatyana Matrosovich, Jackie Carr, Noel A. Roberts, Hans-Dieter Klenk

J Virol. 2003 Aug; 77(15): 8418–8425. doi: 10.1128/JVI.77.15.8418-8425.2003

PMCID:: PMC165236

Abstract Article PDF–497K

Select item 1035149915.

Molecular Identification of UDP-Sugar-Dependent Glycosyltransferase and Acyltransferase Involved in the Phenylethanoid Glycoside Biosynthesis Induced by Methyl Jasmonate in Sesamum indicum L.

Yushiro Fuji, Kai Uchida, Tomoyoshi Akashi, Takashi Ohtsuki, Hiroshi Matsufuji, Masami Yokota Hirai

Plant Cell Physiol. 2023 Jul; 64(7): 716–728. Published online 2023 May 26. doi: 10.1093/pcp/pcad053

PMCID:: PMC10351499

Abstract Article PDF–1.8M

Select item 531319316.

Distinct susceptibility and applicability of MDCK derivatives for influenza virus research

Shih-Chao Lin, Matthew A. Kappes, Mei-Chun Chen, Chi-Chen Lin, Tony T. Wang

PLoS One. 2017; 12(2): e0172299. Published online 2017 Feb 16. doi: 10.1371/journal.pone.0172299

PMCID:: PMC5313193

Abstract Article PDF–1.7M

Select item 853856317.

Cell-Adapted Mutations and Antigenic Diversity of Influenza B Viruses in Missouri, 2019–2020 Season

Cynthia Y. Tang, Karen Segovia, Jane A. McElroy, Tao Li, Minhui Guan, Xiaojian Zhang, Shamita Misra, Jun Hang, Xiu-Feng Wan

Viruses. 2021 Oct; 13(10): 1896. Published online 2021 Sep 22. doi: 10.3390/v13101896

PMCID:: PMC8538563

Abstract Article PDF–13M

Select item 579092618.

Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein

Julie Huiyuan Xiao, Pramila Rijal, Lisa Schimanski, Arun Kumar Tharkeshwar, Edward Wright, Wim Annaert, Alain Townsend

J Virol. 2018 Feb 15; 92(4): e00941-17. Prepublished online 2017 Dec 6. Published online 2018 Jan 30. doi: 10.1128/JVI.00941-17

PMCID:: PMC5790926

Abstract Article PDF–3.4M

Select item 291238919.

Oseltamivir–Resistant Pandemic H1N1/2009 Influenza Virus Possesses Lower Transmissibility and Fitness in Ferrets

Susu Duan, David A. Boltz, Patrick Seiler, Jiang Li, Karoline Bragstad, Lars P. Nielsen, Richard J. Webby, Robert G. Webster, Elena A. Govorkova

PLoS Pathog. 2010 Jul; 6(7): e1001022. Published online 2010 Jul 29. doi: 10.1371/journal.ppat.1001022

PMCID:: PMC2912389

Abstract Article PDF–640K

Select item 1036351020.

Complete biosynthesis of the phenylethanoid glycoside verbascoside

Yihan Yang, Daoyi Xi, Yanan Wu, Tao Liu

Plant Commun. 2023 Jul 10; 4(4): 100592. Published online 2023 Mar 20. doi: 10.1016/j.xplc.2023.100592

PMCID:: PMC10363510

Abstract Article PDF–2.0M

<< First< Prev

Page of 26

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for SIAT1

Fig. 2

The expression of SIAT 1 in Vero and MDCK cells. The expression of SIAT1 RNA (422 bp fragment) as a product of RT-PCR on RNA extracts from Vero (a) and MDCK cells (b). Dot-blot analysis showing protein expression of SIAT1 in Vero (d) and MDCK cells (e). Protein expression intensity of SIAT1 measured by confocal microscopy (f, h). Protein location of SIAT1 is shown by confocal microscopy (g, i)

The expression of essential components for human influenza virus internalisation in Vero and MDCK cells

Cytotechnology. 2014 May;66(3):515-523.
Figure 2

N-glycans released from extracts of SIAT1 cells by treatment with PNGase F, permethylated, and analyzed by MALDI-TOF MS. The medial molecular range between m/z 1500 and 5500 is shown. Putative structures based on compositions and corresponding to masses detected are represented next to the corresponding mass peaks. (A) N-glycans from SIAT1 cells at passage 3. (B) N-glycans in (A) from extracts of SIAT1 cells at passage 3 were treated with neuraminidase A and analyzed. (C) N-glycans in (A) from extracts of SIAT1 cells at passage 3 were treated with neuraminidase S and analyzed. The assignments of N-glycan mass and compositions, as well as relative percentage abundance of each glycan species in (A), (B), and (C) are presented in Supplementary Table .

Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies

Sci Rep. 2022;12:12757.
Figure 3Spectra replicates of human influenza A virus reference strain (“Influenza A-MDCK SIAT1 infected cells”, red spectra) and of the influenza B reference strain (“Influenza B-MDCK SIAT1 infected cells”, green spectra) analysed by ClinProTools Software.

The x-axis records the m/z value, the y-axis the peaks intensity expressed in arbitrary units (a.u.) and the z-axis the loading order.

Identification of different respiratory viruses, after a cell culture step, by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS)

Sci Rep. 2016;6:36082.
Figure 4Representative MALDI-TOF mass spectra of influenza A and B infected cell cultures (“Influenza A-MDCK SIAT1 infected cells” and “Influenza B-MDCK SIAT1 infected cells”) showing peaks in Linear Positive mode acquired in high molecular weight, with pointed average masses, compared with the spectra of uninfected cell cultures (“MDCK SIAT1 control uninfected cells”) in the m/z range of 13–80 KDa.

The x-axis records the m/z value and the y-axis the intensity expressed in arbitrary units (a.u.) of each peak. All spectra were baseline subtracted, smoothed, normalized and realigned. Molecular weight values of virus and cellular discriminant peaks are indicated on peak tops.

Identification of different respiratory viruses, after a cell culture step, by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS)

Sci Rep. 2016;6:36082.